Insider Transactions in Q1 2022 at Biodelivery Sciences International Inc (BDSI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Jeffrey Allen Bailey Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
105,133
-100.0%
|
-
|
|
Mar 22
2022
|
Todd C Davis Director |
SELL
Other acquisition or disposition
|
Direct |
252,207
-100.0%
|
-
|
|
Mar 22
2022
|
Peter Greenleaf Director |
SELL
Other acquisition or disposition
|
Direct |
105,034
-100.0%
|
-
|
|
Mar 22
2022
|
Kevin Kotler Director |
SELL
Other acquisition or disposition
|
Indirect |
7,588,395
-100.0%
|
-
|
|
Mar 22
2022
|
Scott M. Plesha Officer |
SELL
Other acquisition or disposition
|
Direct |
345,127
-100.0%
|
-
|
|
Mar 22
2022
|
Mark A Sirgo Director |
SELL
Other acquisition or disposition
|
Direct |
1,166,866
-100.0%
|
-
|
|
Mar 22
2022
|
Thomas B Smith Chief Medical Officer |
SELL
Other acquisition or disposition
|
Direct |
52,530
-100.0%
|
-
|
|
Mar 22
2022
|
Vanila Singh Director |
SELL
Other acquisition or disposition
|
Direct |
35,851
-100.0%
|
-
|
|
Mar 22
2022
|
W. Mark Watson Director |
SELL
Other acquisition or disposition
|
Direct |
90,663
-100.0%
|
-
|
|
Mar 09
2022
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+4.83%
|
-
|
|
Feb 11
2022
|
Kevin Kotler Director |
BUY
Conversion of derivative security
|
Indirect |
2,422,222
+24.2%
|
$2,422,222
$1.8 P/Share
|
|
Feb 04
2022
|
James Vollins Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,872
-100.0%
|
$29,616
$3.66 P/Share
|
|
Feb 04
2022
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
18,541
-65.26%
|
$55,623
$3.6 P/Share
|
|
Jan 31
2022
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,203
+3.45%
|
-
|
|
Jan 31
2022
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,137
+18.57%
|
-
|
|
Jan 31
2022
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,215
+13.57%
|
-
|
|
Jan 27
2022
|
Todd C Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+2.96%
|
-
|
|
Jan 27
2022
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,050
+6.16%
|
-
|
|
Jan 27
2022
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,276
+50.0%
|
-
|
|
Jan 27
2022
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,361
+31.75%
|
-
|
|
Jan 27
2022
|
Peter Greenleaf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,246
+8.89%
|
-
|
|
Jan 27
2022
|
Kevin Kotler Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,684
+0.15%
|
-
|
|
Jan 27
2022
|
Mark A Sirgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+0.65%
|
-
|
|
Jan 27
2022
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+17.65%
|
-
|
|
Jan 27
2022
|
W. Mark Watson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+7.81%
|
-
|